Article

An attenuated vaccinia vaccine encoding the SARS-CoV-2 spike protein elicits broad and durable immune responses, and protects cynomolgus macaques and human ACE2 transgenic mice from SARS-CoV-2 and its variants

2022-06-13

Abstract excerpt

As long as the coronavirus disease 2019 (COVID-19) pandemic continues, new variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with altered antigenicity will emerge. The development of vaccines that elicit robust, broad, and durable protection against SARS-CoV-2 variants is urgently needed. We have developed a vaccine (rDIs-S) consisting of the attenuated vaccinia virus DIs strain platform car...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f6c5d289-5b1f-5eef-ae31-fe891053816e
DOI: 10.1101/2022.06.12.495779

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

An attenuated vaccinia vaccine encoding the SARS-CoV-2 spike protein elicits broad and durable immune responses, and protects cynomolgus macaques and human ACE2 transgenic mice from SARS-CoV-2 and its variantsDOI 10.1101/2022.06.12.495779Read

Replication-competent vesicular stomatitis virus vaccine vector protects against SARS-CoV-2-mediated pathogenesisSemantic proximity Read

A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infectionSemantic proximity Read

COVID-19 Variants and Vaccine DevelopmentSemantic proximity Read

COVID-19 Variants and Vaccine Development.Semantic proximity Read

T cell-mediated protection against lethal SARS-CoV-2 challenge by a synthetic long peptide vaccine targeting conserved CD4+ and CD8+ T cell epitopesSemantic proximity Read

Combination of a Sindbis-SARS-CoV-2 spike vaccine and αOX40 antibody elicits protective immunity against SARS-CoV-2 induced disease and potentiates long-term SARS-CoV-2-specific humoral and T-cell immunitySemantic proximity Read

A computationally designed antigen eliciting broad humoral responses against SARS-CoV-2 and related sarbecovirusesSemantic proximity Read

Single-epitope T cell–based vaccine protects against SARS-CoV-2 infection in a preclinical animal modelSemantic proximity Read

Intranasal delivery of a rationally attenuated SARS-CoV-2 is immunogenic and protective in Syrian hamstersSemantic proximity Read

SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 elicits immunogenicity in baboons and protection in miceSemantic proximity Read

Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA SARS 2 S in preclinical vaccinationSemantic proximity Read

Prophylactic domain-based vaccine against SARS-CoV-2, causative agent of COVID-19 pandemicSemantic proximity Read